Kornasiewicz Oskar, Hołówko Wacław, Grąt Michał, Gorski Zuzanna, Dudek Krzysztof, Raszeja-Wyszomirska Joanna, Krawczyk Marek
Department of General, Transplant and Liver Surgery, Medical University of Warsaw, Warsaw, Poland.
Clin Transplant. 2016 Oct;30(10):1230-1235. doi: 10.1111/ctr.12807. Epub 2016 Sep 5.
This study was conducted to evaluate the predisposing factors, microbiology, treatment, and outcomes associated with hepatic abscess, a rare but serious complication which may accur after an orthotopic liver transplant (OLT).
This was a retrospective study based on a prospectively maintained database of 1100 patients who underwent OLT at the Medical University of Warsaw. An abscess was defined on imaging as solitary or multiple localized parenchymal collections in patients with clinical signs of infection, with or without positive cultures from blood or abscess aspirate.
Fifteen patients (1.4%) developed hepatic abscess, including 12 (80%) with multiple abscesses. Predisposing factors included biliary pathology (eight patients), hepaticojejunostomy (six patients), and hepatic artery stenosis or thrombosis (five patients). Ten patients were treated using multiple percutaneous and endoscopic interventional procedures in addition to antimicrobial treatment whereas five were treated solely with antibiotics. Five patients (33.3%) died due to multi-organ failure secondary to abscess treatment, including one unsuccessful case of re-OLT. Thirteen patients (87%) had bacterial growth and five (33.3%) had fungal growth in their blood or abscess aspirates.
Hepatic abscess after liver transplantation may be treated successfully with percutaneous and endoscopic intervention, along with antibiotics according to the results of microbial cultures of blood and/or abscess aspirates.
本研究旨在评估肝脓肿的诱发因素、微生物学、治疗方法及预后。肝脓肿是原位肝移植(OLT)后可能出现的一种罕见但严重的并发症。
这是一项基于华沙医科大学前瞻性维护的1100例接受OLT患者数据库的回顾性研究。影像学上,脓肿定义为有感染临床体征的患者出现的单个或多个局限性实质内积液,无论血培养或脓肿穿刺培养是否阳性。
15例患者(1.4%)发生肝脓肿,其中12例(80%)为多发性脓肿。诱发因素包括胆道病变(8例)、肝空肠吻合术(6例)和肝动脉狭窄或血栓形成(5例)。10例患者除接受抗菌治疗外,还接受了多次经皮和内镜介入治疗,而5例仅接受抗生素治疗。5例患者(33.3%)因脓肿治疗继发多器官功能衰竭死亡,其中1例再次OLT未成功。13例患者(87%)血液或脓肿穿刺液中有细菌生长,5例(33.3%)有真菌生长。
肝移植后肝脓肿可根据血液和/或脓肿穿刺液微生物培养结果,通过经皮和内镜介入治疗以及抗生素治疗成功治愈。